Trinucleotide repeat length instability and age of onset in Huntington's disease

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy

Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801

Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member

Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754

A polymorphic DNA marker genetically linked to Huntington's disease

Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080

Myotonic Dystrophy Mutation: an Unstable CTG Repeat in the 3′ Untranslated region of the Gene

Mahadevan, M. S., Tsilfidis, C., Sabourin, L. A., Shutler, G., Amemiya, C. T., Jansen, G., Neville, C., Narang, M. A., Barceló, J. M., O'Hoy, K., et al. (1992) · Science · doi:10.1126/science.1546325 · Cited by 1,656

Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1

Orr, H. T., Chung, M.-Y., Banfi, S., Kwiatkowski, T. J., Servadio, A., Beaudet, A. L., McCall, A. E., Duvick, L. A., Ranum, L. P. W., & Zoghbi, H. Y. (1993) · Nature Genetics · doi:10.1038/ng0793-221 · Cited by 1,632

An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy

Fu, Y., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,453

Huntington’s Disease and DRPLA: Two Glutamine Repeat Diseases

Ross, C. A., Bêcher, M. W., & Koliatsos, V. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_23 · Cited by 2

Autophagy and Huntington’s disease

Mano, T., & Iwata, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00001-0 · Cited by 1

Genetic characterisation of ATXN2 in Australian amyotrophic lateral sclerosis

Wu, S., McCann, E. P., Fat, S. C. M., Grima, N., Henden, L., Fearnley, L. G., Chiu, P., Williams, K. L., Rowe, D. B., Nicholson, G. A., et al. (2025) · Brain Disorders · doi:10.1016/j.dscb.2025.100301 · Cited by 1

Genetic testing for Huntington's disease: Past, present and future. How could genetic data be used to improve clinical practice?

Moss, D. J. H., Ireland, R., Chapman, G., MacLeod, R., Labrum, R. W., Polke, J. M., Monckton, D. G., Holmans, P., EHDN Genetic Modifiers Working group, EHDN Genetic Counselling and Testing Working Group, et al. (2025) · Journal of Huntington s Disease · doi:10.1177/18796397251391953 · Cited by 1

Indole Scaffolds in Neurological Therapeutics: Synthesis, Structure- Activity Relationships and Drug-Receptor Interactions

Bano, A., Khan, A. A., Kushwaha, S. P., -, A., Zaidi, S. M. H., Hasan, S. S., & Fatima, A. (2026) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575415521251021091530 · Cited by 2

DNA methylation profiling in Huntington’s disease reveals disease associated changes in the striatum

Wheildon, G., Smith, A. R., Weymouth, L. S., Harvey, J., Kouhsar, M. P., MacBean, L. F., Troakes, C., Pishva, E., Smith, R. G., & Lunnon, K. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02082-4 · Cited by 2

Animal Models for Huntington's and Parkinson's Diseases

Saxena, M. T. (2013) · Materials and Methods · doi:10.13070/mm.en.3.205 · Cited by 1

A family with mild clinical manifestations of spinocerebellar ataxia type 1 (SCA1): correlation with smaller CAG repeats

Kameya, T., Abe, K., Aoki, M., & Itoyama, Y. (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00138.x · Cited by 1

β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

Vittori, A., REGISTRY investigators of the European Huntington's Disease Network, Orth, M., Roos, R. A. C., Outeiro, T. F., Giorgini, F., & Hollox, E. J. (2013) · Journal of Huntington s Disease · doi:10.3233/jhd-130047 · Cited by 1

Evaluation of IP-RP-HPLC for Length Determination of the Trinucleotide Repeat Fragments in Huntington's Disease

Skrzypczak-Zielińska, M., Heinritz, W., Schulz, A. M., Mierzejewski, M., & Froster, U. G. (2010) · Journal of Chromatographic Science · doi:10.1093/chromsci/48.1.55 · Cited by 1

Mini‐symposium: Huntington's disease ‐ introduction

Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12431 · Cited by 1

Huntington’s Disease

Cuturic, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-38606-1_8 · Cited by 2

Human Genome & Diseases: Review Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies

Borrell-Pagés, M., Zala, D., Humbert, S., & Saudou, F. (2006) · Cited by 1

Mitochondrial Dysfunction in Brain and Muscle Pathology of Huntington’s Disease

Rivera, S., McMurray, C. T., & Ayala‐Peña, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_133 · Cited by 1

Huntington disease

Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1

Huntington Disease and Other Choreas

Videnović, A., & Shannon, K. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-120-2_2 · Cited by 2

Suppression of Somatic Expansion As a Novel Therapeutic Approach for Huntington Disease and Other Repeat Expansion Disorders

Antonijevic, I. A., Bettencourt, B. R., Bialek, P., Ge, P., Ding, S.-Y., Lai, G., Hedde, J. R., Asp, E., Seth, M., Marnellos, G., et al. (2022) · GEN Biotechnology · doi:10.1089/genbio.2021.0012 · Cited by 1

Applications of fMRI to Neurodegenerative Disease

Mahmoud, S. Y., Moon, D., Lee, J. K., & Jones, S. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-10909-6_36 · Cited by 1

Altered RNA Metabolism in Neurodegenerative Disorders

Chimata, A. V., Deshpande, P., & Singh, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4288-2_9 · Cited by 1

Cellular and Molecular Mechanisms of Neuronal Dysfunction in Huntington's Disease

Caboche, J., Vanhoutte, P., Boussicault, L., Roze, E. F., & Bétuing, S. (2016) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-802206-1.00045-3 · Cited by 1

De-Novo Ligand Design against Mutated Huntington Gene by Ligand-based Pharmacophore Modeling Approach

Munir, A., Malik, S. I., & Malik, K. A. (2018) · Current Computer - Aided Drug Design · doi:10.2174/1573409915666181207104437 · Cited by 1

Juvenile Huntington' Disease: A Case of Paternal Transmission with an Uncommon CAG Expansion

Agostinho, L. D. A., Vasconcellos, L. F., da, S. V. C., Apolinário, T. A., da Silva, G. M., Spitz, M., & Antão, P. C. L. (2019) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410253 · Cited by 1

Huntington’s Disease Case Study

Sanders, K. M., & Burdick, D. J. (2019) · Springer eBooks · doi:10.1007/978-1-4939-8722-1_19 · Cited by 1

Caenorhabditis elegans as a model organism for protein homeostasis diseases

Good, S. C., & van Oosten‐Hawle, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819132-3.00003-8 · Cited by 1

Atuação Fisioterapêutica na Doença de Huntington

Vieira, R. T., Inácio, D. M., Fonseca, L. P. D. S., & Caixeta, L. F. (2001) · Revista Neurociências · doi:10.34024/rnc.2011.v19.8364 · Cited by 1

Neuroprotective effects of amantadine–flavonoid conjugates

Fourie, P. M. (2011) · Cited by 1

Huntington Disease and Other Genetic Choreas

Ha, A. D., & Jankovic, J. J. (2011) · Wiley eBooks · doi:10.1002/9781444346183.ch10 · Cited by 1

Sequence Analysis by Numbers: Proteins

Yan, J. F. (1996) · Polymer-Plastics Technology and Engineering · doi:10.1080/03602559608004056 · Cited by 1

Comparison of expanded CAG repeat tracts in sperm and lymphocyte DNA from Machado Joseph disease and spinocerebellar ataxia type I patients

Maurer, D. J., Benzow, K. A., Schut, L. J., Ranum, L. P. J., & Livingston, D. M. (1998) · Human Mutation · doi:10.1002/humu.1380110126 · Cited by 1

Disease Modifying Agents for Huntington??s Disease

Clarke, H., & Feigin, A. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00005 · Cited by 1

Maladies par expansion de polyglutamine

Lèbre, A.-S., & Brice, A. (2000) · Annales de l Institut Pasteur / Actualités · doi:10.1016/s0924-4204(00)80010-4 · Cited by 1

Genetic counselling implications for intermediate allele predictive test results for Huntington disease

Semaka, A. (2013) · cIRcle (University of British Columbia) · doi:10.14288/1.0071843 · Cited by 1

Non-Alzheimer's degenerative dementias

Dihenia, B., & Green, R. C. (1995) · Current Opinion in Psychiatry · doi:10.1097/00001504-199501000-00013 · Cited by 1

à la CART

Smith, O. (1998) · Nature Medicine · doi:10.1038/nm0698-670 · Cited by 1

Molecular Genetic Advances in Neurodegenerative Disorders

Aguilera, A. J. (1995) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30307-x · Cited by 1

Knock-in and Knock-out Models of Huntington Disease

Dietrich, P., & Dragatsis, I. (2005) · Elsevier eBooks · doi:10.1016/b978-012088382-0/50028-1 · Cited by 1

Investigation of the Epigenetic Landscape at Disease-causing Polymorphic Repeat Loci

Mador-House, K. R. (2014) · TSpace (University of Toronto) · Cited by 1

Locating Genetic Modifiers for Inherited Neurodegenerative Diseases

Farrer, L. A. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_12 · Cited by 1

The timing and impact of psychiatric, cognitive and motor abnormalities in Huntington’s diseasePreprint

McAllister, B., Gusella, J. F., Landwehrmeyer, G. B., Lee, J.-M., MacDonald, M. E., Orth, M., Rosser, A., Williams, N. M., Holmans, P., Jones, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.26.116798 · Cited by 1

Expansion of triplet nucleotide repeats in primates and other vertebrates: an evolutionary perspectivePreprint

Murthy, S., & Mishra, R. K. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.05.535742 · Cited by 1

The targeting of non-fibrillar polyQ via distinct VCP-proteasome couplingPreprint

Zhao, D. Y., Mi, C., Wagner, J., Jiang, W., Saha, I., Poege, M., Xu, P., Plitzko, J. M., Guo, Q., Beck, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.01.646186 · Cited by 2

High Frequency of Repeat Expansions in UK Biobank Suggests Protective Rare Variants Modulate C9ORF72 Penetrance in NeurodegenerationPreprint

Molinari, E., Nickerson, A. P., Quistrebert, J., & Kless, A. (2025) · medRxiv · doi:10.1101/2025.09.18.25336048 · Cited by 1

Loss of interruption in the HTT CAG repeat is associated with increased somatic expansion and loss of medium spiny neurons in HDPreprint

Kay, C., Dawson, J. Q., Mätlik, K., Black, H. F., Harvey, E. M., Bortnick, S., Javier, K., Buchanan, C. M., Soomarooah, T., Brás, I. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.02.709181 · Cited by 1

Peripheral and cerebral metabolic features in an animal model of huntington's disease expressing full-length mutant huntingtin

Lopes, C. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Experimental Models of Brain Disease: MRI Studies

van der Weerd, L., Thomas, D. L., Thornton, J. S., Choy, M., & Lythgoe, M. F. (2007) · Springer eBooks · doi:10.1007/1-4020-3910-7_97

Huntington's Disease

Koroshetz, W. J. (2003) · Elsevier eBooks · doi:10.1016/b0-44-306557-8/50128-3

The Aging Male and Impact on Offspring

Jenkins, T. G., Aston, K. I., & Carrell, D. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7187-5_3

Trinucleotide repeats and human diseases

Verma, R. S. (1998) · Advances in genome biology · doi:10.1016/s1067-5701(98)80008-9

Molekulare Grundlagen neurologischer Trinukleotidblockexpansionssyndrome

Epplen, J. T., & Haupt, A. (2000) · Springer eBooks · doi:10.1007/978-3-642-57043-8_18

Transgenic nematodes as a model for Parkinson's disease

Bodhicharla, R. K. (2012) · Nottingham ePrints (University of Nottingham)

Inhibition of specific histone deacetylases suppresses pathogenesis in a Drosophila model of Huntington’s disease

Pallos, J. (2012) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1071

Genetic Basis of Neurologic and Neuromuscular Diseases

Nagan, N., Klein, C. J., Dawson, D. B., Wick, M. J., & Thibodeau, S. N. (2006) · Humana Press eBooks · doi:10.1385/1-59259-928-1:267

Application of a Drosophila model to study Huntington's disease pathogenesis in vivo

Bodai, L. (2004) · SZTE Repository of Dissertations (University of Szeged)

Molecular Genetics and Prenatal Diagnosis

Phillips, J. A. (2009) · Wiley eBooks · doi:10.1002/9781444314342.ch11

Marine Natural Products for Protein Misfolding Modulation

James, C., & Vanya, K. (2013) · InTech eBooks · doi:10.5772/54585

Localization and function of the Drosophila huntingtin protein

Mediatore, J. D. (2007) · DSpace@MIT (Massachusetts Institute of Technology)

Polyglutamine Aggregates as a Model for Protein‐misfolding Diseases

Kim, S., Morley, J. F., Ben‐Zvi, A., & Morimoto, R. I. (2005) · Wiley eBooks · doi:10.1002/9783527619498.ch69

Huntington's Disease

Gendelman, S., Gendelman, H. E., & Ikezu, T. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_28

Applications of fMRI to Neurodegenerative Disease

Mahmoud, S. Y., Jones, S. E., & Phillips, M. D. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0345-7_32

Expression profiling and functional studies of non-coding RNAs in the central nervous system

Dubinsky, A. N., Wilson, M. E., Russo, A. F., Bassuk, A. G., McCray, P. B., & Davidson, B. L. (2011) · doi:10.17077/etd.um0zdvm1

Transfert de genes a potentiel therapeutique dans des modeles de la maladie de huntington developpes chez le rat

Bemelmans, A. (1999)

Estudio de las vías de supervivencia y muerte neuronal en modelos de la enfermedad de Huntington

Rubia, P. P. (2010) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Huntington's Disease for Brain Mapping: An Encyclopedic Reference

Tabrizi, S. J., & Gregory, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00076-2

β-cell dysfunction in Huntington's disease

Bacos, K. (2009) · Lund University Publications (Lund University)

Neurogenetics of dementia

Shu, H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.003

Pridopidine in the pharmacological treatment of Huntington’s disease

Michl, M., Schnopfhagen, K., & Bonelli, R. M. (2013) · Clinical Investigation · doi:10.4155/cli.13.54

A Sau3A polymorphism in the 5? end of the IT15 gene that nonrandomly segregates with the Huntington disease trinucleotide expansion

Carlock, L. R., Gutridge, K., & Vo, T. D. (1994) · Human Genetics · doi:10.1007/bf00201675

Maladies par expansion de polyglutamine Données moléculaires et physiopathologiques

Lèbre, A.-S., & Brice, A. (1997) · Journal of Engineering and Technology Management · doi:10.1016/s0923-4748(97)80010-0

Assessing risk assessment: genetic testing and screening for complex disease

Cox, S. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00681.x

Scope of Trinucleotide Repeat Disorders

Tsuji, S. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_4

B10 The role of n-terminal phosphorylation in huntingtin's oligomerisation, aggregation and toxicity

Herrera, F., dos Santos, J. B., & Outeiro, T. F. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303524.26

Genetics of Movement Disorders: An Abbreviated Overview

Thyagarajan, D. E. (2001) · Stereotactic and Functional Neurosurgery · doi:10.1159/000064597

The new genetics in psychiatry

Feldman, E. (1995) · Advances in Psychiatric Treatment · doi:10.1192/apt.1.4.109

Cognitive and synaptic dysfunction in a mouse model of Huntington's disease

Mitchell, R. C. (2012) · Discovery Research Portal (University of Dundee)

The kinetics and thermodynamics of polyglutamine aggregation

Landrum, E. (2013) · D-Scholarship@Pitt (University of Pittsburgh)

Bioenergetic Defects and Oxidative Damage in Transgenic Mouse Models of Neurodegenerative Disorders

Browne, S. E. (2003) · Defense Technical Information Center (DTIC) · doi:10.21236/ada419306

Prospective memory deficits in Huntington's disease and the impact on daily living

Nicoll, D. R. (2013) · CSUN ScholarWorks (California State University, Northridge)

Study of novel pathogenic mechanisms in Huntington disease

Alberti, S. (2013)

FRAGILE X SYNDROME IN NORTHERN FINLAND

Väisänen, M. (1999)

The Disease Protein Huntingtin and Neuronal Protein Aggregations in Huntington’s Disease (HD)

Rüb, U., Vonsattel, J. P., Heinsen, H., & Korf, H. (2015) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-19285-7_9

Overexpressing Fragments of CREB-Binding Protein (CBP) to Block Transcriptional Dysregulation and Toxicity in Huntington's Disease

Hosier, G. W. (2012) · DalSpace (Dalhousie University)

Neurogenetics: now and the future.

Jb, M. (1995) · PubMed Central

Correlations between molecular and clinical data in Huntington's disease and implications for predictive testing

Claes, S. J., Decruyenaere, M., Dom, R., Malfroid, M., Evers‐Kiebooms, G., Baro, F., Godderis, J., Fryns, J., & Cassiman, J. (1995) · Acta Neuropsychiatrica · doi:10.1017/s0924270800033597

Population Genetics of Ovis and Phylogenetics of Caprinae: A Comparison of Different Genetic Markers for Evaluation of Diversity at Multiple Taxonomic Levels

Driscoll, C. C. (2014) · CU Scholar (University of Colorado Boulder)

Huntington's disease Clinical features and etiology.

金澤, 一. (1998) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.87.1647

Eine epidemiologische Studie im süddeutschen Raum

Rehm, M. M. (2004)

Análisis molecular de familias uruguayas con Enfermedad de Huntington Molecular analysis of the Uruguayan families with Huntington's Disease

Raggio, V. E., Agregado, P., Vita, M., & Buzó, R. (2014)

MEASUREMENTS OF DOPAMINE RELEASE AND UPTAKE IN HUNTINGTON'S DISEASE MODEL RODENTS

Kaplan, S. V., Fowler, S. C., & Johnson, M. A. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814619776_0014

Huntington's Disease: Unraveling the Pathophysiological Cascade Behind a Singular Gene Defect

Kosinski, C. M., Landwehrmeyer, G. B., & Ludolph, A. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_11

Huntington disease (HD)

Firth, H. V., Hurst, J. A., & Hall, J. G. (2005) · Oxford University Press eBooks · doi:10.1093/med/1.1.med-9780192628961-div1-003032

H05 Gene expression profile in fibroblasts of Huntington's disease patients and controls

Marchina, E., Bozzato, A., Ferraboli, S., Agosti, C., Rozzini, L., Borsani, G., Barlati, S., & Padovani, A. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.222653.5

Huntington’s Disease

Raymond, L. A., & Leavitt, B. R. (2005) · Neurological disease and therapy · doi:10.1201/9780849358364.ch16

Genetics of Huntington Disease (HD), HD-Like Disorders, and Other Choreiform Disorders

Walker, R. H. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00030-5

Avaliação cerebelar por morfometria baseada em voxel (VBM) e correlação entre marcadores clínicos e achados de ultrassonografia transcraniana em indivíduos com doença de Huntington

de Azevedo, P. C. (2015) · doi:10.47749/t/unicamp.2015.965313

Attentional dysfunction as a prodrome for Huntington's disease

Margison, S. (2000) · Leicester Research Archive (University of Leicester)

A study of depression in Huntington's disease

Pang, T. Y. (2008) · Minerva Access (University of Melbourne)

2016 William Allan Award: Human Disease Research: Genetic Cycling and Re-cycling 1

Gusella, J. F. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.008

Poly-L-Glutamine Forms Cation Channels: Relevance to the Pathogenesis of the Polyglutamine Diseases

Biophys, J. (2000)

Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

Ranen, N. G., Stine, O. C., Abbott, M. H., Sherr, M., Codori, A., Franz, M. L., Chao, N. I., Chung, A., Pleasant, N. D., & Callahan, C. (1995) · PubMed Central · Cited by 238

Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15

Stine, O. C., Pleasant, N. D., Franz, M. L., Abbott, M. H., Folstein, S. E., & Ross, C. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1547 · Cited by 233

Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.

Trottier, Y., Biancalana, V., & Mandel, J. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.5.377 · Cited by 202

Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene

Zühlke, C., Rieß, O., Bockel, B., Lange, H., & Thies, U. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.12.2063 · Cited by 164

Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease

Novelletto, A., Persichetti, F., Sabbadin, G., Mandich, P., Bellone, E., Ajmar, F., Pergola, M., SENNO, L. D., MacDonald, M. E., Gusella, J. F., et al. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.1.93 · Cited by 57